Bio
Tan Anthony Tanoto received his PhD degree from the National University of Singapore, studying the immunopathogenesis of HBV and characterising the innate and adaptive immune responses in different groups of HBV infected patients. He then joined the Singapore Institute for Clinical Sciences (Agency for Science, Technology and Research, A*STAR) as a postdoctoral fellow, before moving DUKE-NUS Medical school, to continue his research career in HBV immunopathogenesis and treatment of HBV-related liver cancer. He is currently an Assistant Professor in the Emerging Infectious Diseases Programme in DUKE-NUS Medical School.
His research is centred on the study of virus-specific T cell responses in humans, with a primary interest on Hepatitis B virus infection, and the development of T cell immunotherapy for HBV-related liver cancer. He has worked closely with industry and healthcare partners to translate the novel T cell immunotherapy approaches into the clinics. During the COVID-19 pandemic, he has also contributed significantly to the understanding of virus-specific T cell responses in SARS-CoV-2 infection with notable publications in high-impact journals. In addition, he has received funding from the Programme for Research in Epidemic Preparedness and Response and the National Health Innovation Centre to study the T cell responses against other viruses of interest in an effort to use virus-specific T cell response information in addressing clinical questions.
Education
Doctor of Philosophy
National University of Singapore, Singapore
Bachelor of Science in Life Sciences Hons Class 2A
National University of Singapore, Singapore